<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Ilika Plc — News on 6ix</title>
<link>https://6ix.com/company/ilika-plc</link>
<description>Latest news and press releases for Ilika Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 10 Apr 2026 15:01:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/ilika-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835e5ad78dffbe2df12841c.webp</url>
<title>Ilika Plc</title>
<link>https://6ix.com/company/ilika-plc</link>
</image>
<item>
<title>Collaboration with Brompton Bicycles</title>
<link>https://6ix.com/company/ilika-plc/news/collaboration-with-brompton-bicycles</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/collaboration-with-brompton-bicycles</guid>
<pubDate>Fri, 10 Apr 2026 15:01:00 GMT</pubDate>
<description>Ilika plc has announced a £214,000, 12-month joint development programme with Brompton Bicycles to integrate Ilika's 10Ah Goliath solid-state battery prototypes into Brompton's next-generation foldable e-bikes. This collaboration, supported by the Battery Innovation Programme, aims to enhance battery safety and potentially reduce weight, facilitating market expansion for Brompton, particularly in regions with stringent e-bike battery regulations like China, and addressing increasing scrutiny in </description>
</item>
<item>
<title>Positive Feedback on Safety of Goliath Cells</title>
<link>https://6ix.com/company/ilika-plc/news/positive-feedback-on-safety-of-goliath-cells</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/positive-feedback-on-safety-of-goliath-cells</guid>
<pubDate>Wed, 18 Mar 2026 07:00:00 GMT</pubDate>
<description>Ilika plc has announced positive safety test results for its Goliath solid-state battery cells from a UK defence agency, indicating suitability for high-risk applications. Prototypes delivered in December 2025 demonstrated resilience, with a 10Ah cell surviving a single shot before a thermal event was triggered by a second, and low-charge cells showing no thermal event. While a Goliath cell exhibited a delayed reaction before thermal runaway and a lower runaway temperature than conventional NCA </description>
</item>
<item>
<title>First Commercial Delivery to Cirtec Medical</title>
<link>https://6ix.com/company/ilika-plc/news/first-commercial-delivery-to-cirtec-medical</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/first-commercial-delivery-to-cirtec-medical</guid>
<pubDate>Tue, 10 Mar 2026 07:00:00 GMT</pubDate>
<description>Ilika plc has announced the successful completion of its first commercial delivery of Stereax electrode to Cirtec Medical, marking a significant step in its commercial progress. This initial order, which represents Ilika's first revenue-generating shipment to Cirtec, will support the production of Stereax M300 batteries for active implantable medical devices. The electrodes are intended for validation and customer sampling across various applications, including implanted sensors, neurostimulator</description>
</item>
<item>
<title>Award of Share Options</title>
<link>https://6ix.com/company/ilika-plc/news/award-of-share-options-8</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/award-of-share-options-8</guid>
<pubDate>Tue, 24 Feb 2026 10:21:00 GMT</pubDate>
<description>Ilika plc announced on February 24, 2026, the award of share options to Executive Directors and employees under its Long Term Incentive Plan (LTIP) and EMI employee option scheme. A total of 634,956 ordinary shares were granted under the LTIP, with 625,360 options going to one Executive Director at an exercise price of 1p. Additionally, 2,051,219 ordinary shares were granted under the EMI scheme to employees and an Executive Director, with an exercise price of 27.5p. These awards, totaling 2,686</description>
</item>
<item>
<title>Ilika at Yellowstone Investor Evening: Replacement</title>
<link>https://6ix.com/company/ilika-plc/news/ilika-at-yellowstone-investor-evening-replacement</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/ilika-at-yellowstone-investor-evening-replacement</guid>
<pubDate>Thu, 19 Feb 2026 07:00:00 GMT</pubDate>
<description>Ilika plc has announced that its CEO and CFO will present at the Yellowstone Advisory Private Investor evening on February 25, 2026, to showcase the company's growth. This event will not disclose any new material information regarding current trading. The announcement also corrects a previous RNS number 5504T, clarifying that the event was for Ilika Plc and not South32 Limited.
Disclaimer*</description>
</item>
<item>
<title>Half-year Financial Report</title>
<link>https://6ix.com/company/ilika-plc/news/half-year-financial-report-108</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/half-year-financial-report-108</guid>
<pubDate>Thu, 22 Jan 2026 07:00:00 GMT</pubDate>
<description>Ilika plc reported half-year results for the six months ended 31 October 2025, highlighting key milestones in its Stereax and Goliath battery products. The company commenced Stereax prototype production and customer deliveries, with 21 customers evaluating the technology for medical devices and industrial sensors. For its Goliath cells, a customer validated 2Ah prototypes, and the company shipped 10Ah prototypes following the commissioning of its automated pilot line. Ilika secured £1.25 million</description>
</item>
<item>
<title>Ilika Secures Stereax Electrode Order from Cirtec</title>
<link>https://6ix.com/company/ilika-plc/news/ilika-secures-stereax-electrode-order-from-cirtec</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/ilika-secures-stereax-electrode-order-from-cirtec</guid>
<pubDate>Wed, 21 Jan 2026 07:00:00 GMT</pubDate>
<description>Ilika plc has secured its first revenue-generating purchase order from Cirtec Medical for Stereax electrodes, marking a commercial transition in their strategic partnership. This order follows two years of development and successful prototype delivery, supporting Cirtec's ramp-up of Stereax M300 production for active implantable medical devices. This signifies Ilika's entry into the commercial phase for its medical device battery technology, with 21 customers currently evaluating the Stereax M30</description>
</item>
<item>
<title>Initial Stereax M300 Shipments</title>
<link>https://6ix.com/company/ilika-plc/news/initial-stereax-m300-shipments</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/initial-stereax-m300-shipments</guid>
<pubDate>Thu, 18 Dec 2025 07:00:00 GMT</pubDate>
<description>Ilika plc has commenced shipping prototype Stereax M300 solid-state batteries to 21 customers, marking a significant commercial milestone and progressing its 10-year manufacturing agreement with Cirtec Medical. These initial deliveries are intended for testing in active implantable medical devices, including implanted sensors and neurostimulators, with the goal of gathering data for a market estimated at over $40 billion. The company anticipates soliciting feedback from this core customer group </description>
</item>
<item>
<title>Ilika Ships 10Ah Goliath Battery Prototypes</title>
<link>https://6ix.com/company/ilika-plc/news/ilika-ships-10ah-goliath-battery-prototypes</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/ilika-ships-10ah-goliath-battery-prototypes</guid>
<pubDate>Thu, 11 Dec 2025 07:00:00 GMT</pubDate>
<description>Ilika plc has commenced shipping 10Ah Goliath battery prototypes, a significant milestone representing five times the capacity of previous 2Ah prototypes. These new cells feature a proprietary oxide coating designed to improve safety and potentially reduce battery pack weight by 20% and manufacturing costs by £2,500 per vehicle, according to automotive experts. The prototypes were produced on Ilika's newly automated pilot line, which achieved a 93% manufacturing success rate. The company is also</description>
</item>
<item>
<title>Trading Update & Notice of Half-Year Results</title>
<link>https://6ix.com/company/ilika-plc/news/trading-update-and-notice-of-half-year-results-5</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/trading-update-and-notice-of-half-year-results-5</guid>
<pubDate>Thu, 20 Nov 2025 07:00:00 GMT</pubDate>
<description>Ilika plc provided a trading update for the six months ended 31 October 2025, expecting to announce results on 22 January 2026. The company reported that its Stereax manufacturing process for the M300 micro-battery has been qualified by its licensing partner, with initial customer deliveries targeted for Q4 2025. Goliath P1 (2Ah) prototypes have been validated by customer testing, and the company received a £1.25 million grant from the DRIVE35 programme to support the development of generic A-Sa</description>
</item>
<item>
<title>Commissioning Complete for Goliath Pilot Line</title>
<link>https://6ix.com/company/ilika-plc/news/commissioning-complete-for-goliath-pilot-line</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/commissioning-complete-for-goliath-pilot-line</guid>
<pubDate>Tue, 21 Oct 2025 06:00:00 GMT</pubDate>
<description>Ilika plc has announced the completion of the commissioning of its Goliath automated pilot line, which is now fully operational. This 1.5MWh pilot line enables the delivery of solid-state battery prototypes to customers starting in 2025. The facility will produce 10Ah P1.5 prototypes, which are first-generation 10 amp-hour batteries, and initial sampling quantities of its 50Ah P2 prototypes, which are second-generation 50 amp-hour batteries. Ilika remains on track to begin releasing its 10Ah P1.</description>
</item>
<item>
<title>Exercise of Options and Total Voting Rights</title>
<link>https://6ix.com/company/ilika-plc/news/exercise-of-options-and-total-voting-rights-61</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/exercise-of-options-and-total-voting-rights-61</guid>
<pubDate>Wed, 01 Oct 2025 11:00:00 GMT</pubDate>
<description>Ilika plc announced the issuance of 30,000 new ordinary shares of 1p each following the exercise of options under the company's share option schemes. Application has been made for these shares to be admitted to trading on AIM, with admission expected around 8:00 a.m. on October 6, 2025. Following this admission, the company's issued share capital will consist of 180,832,175 ordinary shares. This number can be used by shareholders to calculate their interest in the company under the FCA's Disclos</description>
</item>
<item>
<title>Result of AGM & Award of Executive Share Options</title>
<link>https://6ix.com/company/ilika-plc/news/result-of-agm-and-award-of-executive-share-options</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/result-of-agm-and-award-of-executive-share-options</guid>
<pubDate>Tue, 23 Sep 2025 14:43:00 GMT</pubDate>
<description>Ilika plc announced the successful passing of all resolutions at its Annual General Meeting. Executive Directors were granted options over 253,566 ordinary shares of 1p each on September 22, 2025. These options represent 0.1% of the company's existing issued ordinary share capital and were awarded under the deferred Bonus Scheme. Specifically, CEO Graeme Purdy received options for 186,642 shares, bringing his total options held to 3,728,524, representing 2.1% of issued share capital; he also hol</description>
</item>
<item>
<title>Start of Primed Solid-State Battery Programme</title>
<link>https://6ix.com/company/ilika-plc/news/start-of-primed-solid-state-battery-programme</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/start-of-primed-solid-state-battery-programme</guid>
<pubDate>Mon, 22 Sep 2025 06:00:00 GMT</pubDate>
<description>Ilika plc announced the commencement of its PRIMED programme, effective August 1, 2025, with Jaguar Land Rover and Oxford University providing strategic steering support. This 12-month programme aims to scale up the production of 50Ah solid-state batteries, leveraging the UKBIC's industrial facilities. PRIMED builds on the HISTORY project, which developed a 50Ah solid-state battery prototype, and the SiSTEM programme, which established SSB assembly capabilities. The programme's deliverables incl</description>
</item>
<item>
<title>Notice of AGM and Posting of Annual Report</title>
<link>https://6ix.com/company/ilika-plc/news/notice-of-agm-and-posting-of-annual-report-43</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/notice-of-agm-and-posting-of-annual-report-43</guid>
<pubDate>Thu, 28 Aug 2025 06:00:00 GMT</pubDate>
<description>Ilika plc announced that its Annual General Meeting (AGM) will occur on Tuesday, 23 September 2025, at 2:00 pm (BST) at Eversheds Sutherland LLP in London. The Annual Report and Accounts for the year ended 30 April 2025, along with the Notice of the 2025 AGM, will soon be available for viewing and download. While there will be no Q&A session at the AGM, the company will host an investor presentation via Investor Meet Company at 4:30 pm (BST) on the same day, 23 September 2025. Proxy appointments</description>
</item>
<item>
<title>Stereax Battery Milestone at Cirtec Medical</title>
<link>https://6ix.com/company/ilika-plc/news/stereax-battery-milestone-at-cirtec-medical</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/stereax-battery-milestone-at-cirtec-medical</guid>
<pubDate>Mon, 18 Aug 2025 06:00:00 GMT</pubDate>
<description>Ilika plc (AIM: IKA) announced a manufacturing milestone with partner Cirtec Medical, completing process qualification for Stereax M300 micro-battery production at Cirtec Medical's Lowell, Massachusetts facility. Production has commenced for testing and initial customer deliveries, starting in 2025. This activates a ten-year manufacturing agreement signed in August 2023, combining Ilika's battery technology with Cirtec Medical's manufacturing expertise for miniaturized medical implants.
</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/ilika-plc/news/holdings-in-company-1030</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/holdings-in-company-1030</guid>
<pubDate>Thu, 17 Jul 2025 07:56:00 GMT</pubDate>
<description>Holding(s) in Company.</description>
</item>
<item>
<title>Award of Government Grant Funding</title>
<link>https://6ix.com/company/ilika-plc/news/award-of-government-grant-funding</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/award-of-government-grant-funding</guid>
<pubDate>Tue, 15 Jul 2025 06:00:00 GMT</pubDate>
<description>Award of Government Grant Funding.</description>
</item>
<item>
<title>Notice of Results</title>
<link>https://6ix.com/company/ilika-plc/news/notice-of-results-356</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/notice-of-results-356</guid>
<pubDate>Wed, 11 Jun 2025 13:09:00 GMT</pubDate>
<description>Notice of Results.</description>
</item>
<item>
<title>Result of Oversubscribed Retail Offer</title>
<link>https://6ix.com/company/ilika-plc/news/result-of-oversubscribed-retail-offer-2</link>
<guid isPermaLink="true">https://6ix.com/company/ilika-plc/news/result-of-oversubscribed-retail-offer-2</guid>
<pubDate>Wed, 28 May 2025 17:00:00 GMT</pubDate>
<description>Result of Oversubscribed Retail Offer.</description>
</item>
</channel>
</rss>